Quantum leap innovation from the point of view of start-ups
What really "rocked" the pharmaceutical market? OK, gene therapy, personalized medicine..but the latter may not be finished yet.
Here comes a "gap" that start-ups can or could fill. Here is a list of 3D related start-ups and options:
- 3D Trust: Single integrated platform to interact securely within your factory with different AM machine brands and models. Remotely control and monitor your machines.
- Pin tracker: A system to identify 3D printers by their fingerprints.
- Digital twin for patients
- 3D fingerprint of the patient on the 3D tablet for unique biometric identification
- 3D printer connected in a blockchain to increase output
- 3D Tablet App for OTC Products
- 2D QR Codes as tablet imprint for further patient information
Thus the 3D printing of tablets should establish itself as an interesting and lucrative niche next to the conventional tablets produced by compaction. Even if the mass-produced traditional tablets, which can be produced in large volumes, will still be needed in the future, a new important field for individualized orally effective medicine will emerge.
In this context, however, a possible new problem area of 3D printing should also be mentioned. As soon as 3D printing can also be used for tablet production by many laypeople using inexpensive printers and printing processes, many counterfeits of conventionally produced tablets will be offered illegally. This danger must be recognised and countermeasures taken in good time. For example, a fingerprint (in the figurative sense) of a 3D printed product can be determined by using specialized algorithms. This seems to be important at the moment to detect 3D printed weapons or counterfeit keys, but should also be used for 3D "fake tablets". So it may be possible to determine which printer was used for the production of the product. The technology called PrinTracker is being developed as software for law enforcement.
So it's again exciting to see how the weaknesses of innovative production can be at least partially eliminated by new innovations. If innovations fundamentally change products as well as initiate a new business model, then start-ups should actually become interested. How do start-ups (or those who want to become start-ups) judge this assessment of the quantum leap potential of the 3D tablet?
Note: the entire article represents the opinion of the author and not that of any of his previous or current employers and this publication is not supported by them in any way.
Interested in more blogs on 3D printing?
In the previous episode a quantum leap innovation from the point of view of innovation managers was explained.
In the next blog the quantum leap innovation from the view of pharmaceutical academic research is described.
Dr. Volker Moeckel
Kommentar schreiben